Loading...
•
Jun 30, 2022
Chemours Q2 2022 Earnings Report
Chemours' second quarter results demonstrated strength with record TSS and APM performance.
Key Takeaways
Chemours reported record net sales of $1.9 billion, up 16% year-over-year, driven by strong demand across all segments. Record Adjusted EBITDA for both TSS and APM. The company is now targeting the high end of Adjusted EBITDA guidance and increasing Free Cash Flow outlook.
Record Net Sales of $1.9 billion, up 16% year-over-year, including record Net Sales in all three segments
Net Income of $201 million with EPS of $1.26, up $0.87 year-over-year
Adjusted Net Income of $302 million with Adjusted EPS of $1.89, up $0.69 year-over-year
Adjusted EBITDA of $475 million, up 30% year-over-year
Chemours
Chemours
Forward Guidance
Chemours anticipates achieving the high end of its full year Adjusted EBITDA range and are raising its cash flow outlook to greater than $600 million.